GenMark Diagnostics to Present at the Canaccord Genuity Medical Technologies & Diagnostics Forum
02 November 2016 - 10:07AM
Business Wire
GenMark Diagnostics, Inc. (NASDAQ: GNMK), a leading provider of
automated, multiplex molecular diagnostic testing systems,
announced today that Hany Massarany, President and Chief Executive
Officer, will present at the Canaccord Genuity Medical Technologies
& Diagnostics Form to be held in New York, NY at the Westin
Grand Central Hotel on Thursday, November 17, 2016 at 1:30 p.m.
Eastern Time. The presentation will be made available at
http://ir.genmarkdx.com.
ABOUT GENMARK DIAGNOSTICS
GenMark Diagnostics (NASDAQ: GNMK) is a leading provider of
automated, multiplex molecular diagnostic testing systems that
detect and measure DNA and RNA targets to diagnose disease and
optimize patient treatment. Utilizing GenMark’s proprietary
eSensor® detection technology, GenMark’s eSensor XT-8® system is
designed to support a broad range of molecular diagnostic tests
with a compact, easy-to-use workstation and self-contained,
disposable test cartridges. The eSensor detection technology is
also incorporated into GenMark’s sample-to-answer system, ePlex®.
For more information, visit www.genmarkdx.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20161101006967/en/
GenMark Diagnostics, Inc.Hany Massarany, 760-448-4325President,
Chief Executive Officer
GenMark Diagnostics (NASDAQ:GNMK)
Historical Stock Chart
From Apr 2024 to May 2024
GenMark Diagnostics (NASDAQ:GNMK)
Historical Stock Chart
From May 2023 to May 2024
Real-Time news about GenMark Diagnostics Inc (NASDAQ): 0 recent articles
More Genmark Diagnostics, Inc. (MM) News Articles